Metagenomi Therapeutics
77 hedge funds and large institutions have $13.2M invested in Metagenomi Therapeutics in 2025 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 28 increasing their positions, 19 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
3.21% less ownership
Funds ownership: 28.67% → 25.46% (-3.2%)
66% less capital invested
Capital invested by funds: $38.7M → $13.2M (-$25.6M)
Holders
77
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$450K | |
| 2 | +$407K | |
| 3 | +$326K | |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
+$322K |
| 5 |
BlackRock
New York
|
+$236K |
Top Sellers
| 1 | -$1.49M | |
| 2 | -$1.39M | |
| 3 | -$540K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$422K |
| 5 |
Goldman Sachs
New York
|
-$222K |